VivoSeq
Infectious Disease

Yellow Fever

0

Pipeline Programs↗

5

Active Trials↗

1

Companies Involved↗

Yellow Fever is an early-stage landscape with 0 programs across 1 company. The most active players are Sanofi.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Sanofi logo

Sanofi

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

17

clinical trials

Completed10 · 59%
Active, not recruiting3 · 18%
Unknown status2 · 12%
Not yet recruiting2 · 12%

Clinical Trials

Trial Activity

17 trials

Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA
Active, not recruiting·Sanofi logoSanofi·Phase 2·NCT04942210·568 enrolled
Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)
Active, not recruiting·TThe Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)·Phase 4·NCT02555072·4,761 enrolled
Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia
Active, not recruiting·Sanofi logoSanofi·Phase 2·NCT05011123·690 enrolled
Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever Vaccination
Not yet recruiting·AANRS, Emerging Infectious Diseases·N/A·NCT05450770·60 enrolled
Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 Months
Not yet recruiting·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 3·NCT06815835·1,530 enrolled
Trial of an Inactivated Yellow Fever Virus Vaccine
Completed·NNajit Technologies, Inc.·Phase 1·NCT05172544·26 enrolled
Yellow Fever Vaccine on Statin/ Non Statin Subjects
Completed·SSingapore General Hospital·Phase 2·NCT03116802·37 enrolled
The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.
Completed·FFrench National Agency for Research on AIDS and Viral Hepatitis·Phase 3·NCT01426243·71 enrolled
Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever Vaccine
Completed·—·Phase 4·NCT01290055·27 enrolled
Trial of Yellow Fever Inactivated Vaccine
Completed·GGE Healthcare·Phase 1·NCT00995865·60 enrolled
Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers
Completed·Sanofi logoSanofi·Phase 3·NCT01436396·792 enrolled
Yellow Fever Virus Vaccine and Immune Globulin Study
Completed·EEmory University·Phase 1·NCT00254826·80 enrolled
Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Humans
Completed·TTysana Pte Ltd·Phase 1·NCT03776786·37 enrolled
Non- Inferiority Fractional-doses Trial for Yellow Fever Vaccine
Completed·UUniversity of Oxford·Phase 4·NCT04059471·900 enrolled
Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults
Completed·Sanofi logoSanofi·Phase 1·NCT04142086·73 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)